Skip to content
Sector Performance
% Price Change
All Sectors
-0.49%
Energy
+1.65%
Real Estate
+0.99%
Consumer Staples
+0.99%
Health Care
+0.24%
Health Care Equipment & Services
+0.24%
Pharmaceuticals, Biotechnology & Life Sciences
+0.25%
Financials
+0.14%
Utilities
+0.13%
Communication Services
-0.23%
Consumer Discretionary
-0.68%
Industrials
-0.88%
Materials
-1.07%
Information Technology
-1.29%
Data last updated as of 4:38 PM EDT 04/28/2026
* The weighted average of intraday total return

Latest Sector News

Biogen Beats Estimates as Alzheimer’s Drug Gains Momentum Biogen Inc.’s first-quarter sales and profit beat expectations, a sign that the company’s Alzheimer’s drug and cost cuts are helping offset pressure on its multiple sclerosis franchise.
Biogen Beats Estimates as Alzheimer’s Drug Gains Momentum
Humana Beats Profit Estimates, Affirms Full-Year Guidance Humana Inc.’s first-quarter profit exceeded Wall Street’s estimates though the company maintained its full-year guidance, suggesting it may foresee difficulties later in the year.
Humana Beats Profit Estimates, Affirms Full-Year Guidance
German Coalition Clears Crucial Healthcare, Budget Packages Chancellor Friedrich Merz’s cabinet approved a healthcare overhaul and a multi-year budget blueprint, laying the groundwork for a push to revive Germany’s economic growth.
German Coalition Clears Crucial Healthcare, Budget Packages
RemeGen Focused on Growing Domestic Business
RemeGen Focused on Growing Domestic Business
Shaojing Tong, CFO at Chinese biotech firm RemeGen, discusses the company's first quarter results and shares his confidence in growth in the domestic market. The company's stock has outperformed all of its peers in the MSCI China Healthcare Index since the start of the year. (Source: Bloomberg)
More Sector News
GiGaSoft
Terms of ServiceTrademarksPrivacy Policy
CareersMade in NYCAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.